SOS LAB CO., LTD. (464080.KQ)
11720.0
(-3.54%)
11720.0
(-3.54%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 4.1 Billion | 2.33 Billion | 1.21 Billion |
| Cost of Revenue | 2.6 Billion | 2.06 Billion | 860.57 Million |
| Gross Profit | 1.5 Billion | 270.93 Million | 353.92 Million |
| Operating Expenses | 9.82 Billion | 9.87 Billion | 7.34 Billion |
| Selling, General and Administrative Expenses | 2.13 Billion | 1.66 Billion | 1.09 Billion |
| Research and Development Expenses | 2.83 Billion | 4.41 Billion | 4.25 Billion |
| Other Expenses | 4.85 Billion | 6.42 Million | 2.06 Million |
| Cost and Expenses | 12.42 Billion | 11.94 Billion | 8.2 Billion |
| Operating Income | -8.32 Billion | -9.6 Billion | -6.99 Billion |
| Interest Expense | 1.91 Billion | 2 Billion | 1.01 Billion |
| Income Tax Expense | - | 220.07 Million | 28.48 Million |
| Earnings before Tax | 6.02 Billion | -20.31 Billion | -18.82 Billion |
| Net Income | 6.02 Billion | -20.31 Billion | -18.82 Billion |
| Earnings Per Share Basic | 691.00 | -3463.00 | -32.26 Thousand |
| Earnings Per Share Diluted | 654.00 | -3463.00 | -32.26 Thousand |
| Weighted Average Shares Outstanding | 8.71 Million | 5.86 Million | 583.51 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 9.2 Million | 5.86 Million | 583.51 Thousand |
| Gross Margin | 0.37 | 0.12 | 0.29 |
| EBIT Margin | -1.78 | -3.82 | -5.59 |
| Profit Margin | 1.47 | -8.70 | -15.50 |
| EBITDA | -7.31 Billion | -8.91 Billion | -6.79 Billion |
| Earnings Before Tax Margin | -2.03 | -4.11 | -5.76 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 467.94 Million | 2.23 Billion | 4.1 Billion | 1.89 Billion | 422.45 Million | 2.33 Billion |
| Cost of Revenue | 207.27 Million | 1.4 Billion | 2.6 Billion | 1.28 Billion | 267.76 Million | 2.06 Billion |
| Gross Profit | 260.67 Million | 828.33 Million | 1.5 Billion | 604.86 Million | 154.68 Million | 270.93 Million |
| Operating Expenses | 3.48 Billion | 3.31 Billion | 9.82 Billion | 1.95 Billion | 3.19 Billion | 9.87 Billion |
| Selling, General and Administrative Expenses | 605.59 Million | 759.77 Million | - | 378.73 Million | 558.99 Million | - |
| Research and Development Expenses | 1.57 Billion | 1.16 Billion | - | -320.4 Million | 1.69 Billion | - |
| Other Expenses | 1.8 Million | 3.62 Million | 3.97 Million | 3.58 Million | 280 Thousand | 6.42 Million |
| Cost and Expenses | 3.69 Billion | 4.72 Billion | 12.42 Billion | 3.23 Billion | 3.46 Billion | 11.94 Billion |
| Operating Income | -3.22 Billion | -2.48 Billion | -8.32 Billion | -1.34 Billion | -3.03 Billion | -9.6 Billion |
| Interest Expense | 38.23 Million | 32.31 Million | 1.91 Billion | 616.02 Million | 634.79 Million | 2 Billion |
| Income Tax Expense | 121.28 Million | 174.06 Million | 331.37 Million | 41.49 Million | 81.06 Million | 220.07 Million |
| Earnings before Tax | -3.13 Billion | -2.36 Billion | 6.02 Billion | -2.75 Billion | -3.59 Billion | -20.31 Billion |
| Net Income | -3.13 Billion | -2.36 Billion | 6.02 Billion | -2.75 Billion | -3.59 Billion | -20.31 Billion |
| Earnings Per Share Basic | -199.00 | -153.00 | - | -443.00 | -587.00 | - |
| Earnings Per Share Diluted | -199.00 | -153.00 | - | -443.00 | -587.00 | - |
| Weighted Average Shares Outstanding | 15.75 Million | 15.44 Million | 8.71 Million | 6.22 Million | 6.12 Million | 5.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 15.75 Million | 15.44 Million | 9.2 Million | 6.22 Million | 6.12 Million | 5.86 Million |
| Gross Margin | 0.56 | 0.37 | 0.37 | 0.32 | 0.37 | 0.12 |
| EBIT Margin | -6.22 | -0.96 | - | -0.60 | -6.61 | - |
| Profit Margin | -6.70 | -1.06 | 1.47 | -1.46 | -8.51 | -8.70 |
| EBITDA | -2.91 Billion | -2.14 Billion | - | -1.13 Billion | -2.79 Billion | - |
| Earnings Before Tax Margin | -6.89 | -1.11 | -2.03 | -0.71 | -7.19 | -4.11 |
FFWC
WBS-PF
DCI
OSB
AUMN
603324